Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its structure supports high enantioselectivity, making it valuable in the production of active pharmaceutical ingredients (APIs) for antidepressants and antipsychotics. Commonly employed in asymmetric synthesis due to the stability and reactivity of the pyrrolidine ring. Also utilized in research settings for the preparation of fluorinated analogs in medicinal chemistry, where the fluorophenyl group enhances metabolic stability and binding affinity.